- Approval Id
- 51f75dc973dbd02e
- Drug Name
- EPIROZIN OINTMENT 2% W/W
- Product Name
- EPIROZIN OINTMENT 2% W/W
- Approval Number
- SIN16306P
- Approval Date
- 2021-08-24
- Registrant
- APEX PHARMA MARKETING PTE. LTD.
- Licence Holder
- APEX PHARMA MARKETING PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- OINTMENT
- Dosage
- **DOSAGE AND ADMINISTRATION**
For external use only. Adult and Children: Apply to the affected area 2 to 3 times a day, for up to 10 days depending on the response. The area may be covered with a dressing or occluded if desired. There is no long-term experience of mupirocin in humans.
Do not mix with other preparations, as there is a risk of dilution, resulting in a reduction in the antibacterial activity and potential loss of stability of the mupirocin.
- Route Of Administration
- TOPICAL
- Indication Info
- **INDICATIONS**
Epirozin Ointment is indicated for the treatment of bacterial skin infections e.g., impetigo, folliculitis and furunculosis.
- Contraindications
- **CONTRAINDICATIONS**
Epirozin Ointment should not be given to patients with a history of hypersensitivity to mupirocin or any of the excipients.
- Atc Code
- D06AX09
- Atc Item Name
- mupirocin
- Pharma Manufacturer Name
- APEX PHARMA MARKETING PTE. LTD.
- Company Detail Path
- /organization/apex-pharma-marketing-pte-ltd
